Innovative/Translational Cancer Research Grant Program

About this program

Mary Kay Ash Foundation’s Innovative/Translational Cancer Research Grant Program supports translational research that links laboratory findings to clinical application to improve diagnosis, prognosis, prevention, or treatment of cancers affecting women (including breast, ovarian, uterine, endometrial, and cervical cancers); grants are awarded up to $100,000 (combined direct and indirect costs) over two years, with the Foundation typically funding 10–15 awards annually. Eligible applicants are NCI-designated cancer institutes and accredited medical schools, with only one application accepted per institution; invitations to apply are extended after review by the Research Review Committee Chair and approval by the Foundation Board. Typical annual cycle opens November 1 and closes February 1, applicants are notified in August, and awards/funds are distributed in September/October in recognition of Breast Cancer Awareness Month.